Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 308126, 9 pages
http://dx.doi.org/10.1155/2014/308126
Research Article

Comparison of the Effects of Acarbose and TZQ-F, a New Kind of Traditional Chinese Medicine to Treat Diabetes, Chinese Healthy Volunteers

1The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, No. 816 Zhenli Road, Hebei District, Tianjin 300150, China
2Tasly Research Institute, Tasly Pharmaceutical Group Co., Ltd., No. 2 Pujihe East Road, Beichen District, Tianjin 300041, China
3Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, No. 312 Anshanxi Road, Nankai District, Tianjin 300193, China
4Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, No. 312 Anshanxi Road, Nankai District, Tianjin 300193, China

Received 13 November 2013; Accepted 11 January 2014; Published 6 April 2014

Academic Editor: Syed Ibrahim Rizvi

Copyright © 2014 Huang Yuhong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Danaei, M. M. Finucane, Y. Lu et al., “National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants,” The Lancet, vol. 378, no. 9785, pp. 31–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, “Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas,” Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137–149, 2014. View at Google Scholar
  3. The DECODE Study Group, European Diabetes Epidemiology Group, “Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria,” The Lancet, vol. 354, no. 9179, pp. 617–662, 1999. View at Google Scholar
  4. K. Osei, S. Rhinesmith, T. Gaillard, and D. Schuster, “Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention,” Diabetes Care, vol. 27, no. 6, pp. 1439–1446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Thalhammer, B. Balzuweit, A. Busjahn, C. Walter, F. C. Luft, and H. Haller, “Endothelial cell dysfunction and arterial wall hypertrophy are associated with disturbed carbohydrate metabolism in patients at risk for cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 5, pp. 1173–1179, 1999. View at Google Scholar · View at Scopus
  6. W. Wang, T. Miura, H. Shi et al., “Effect of Tangzhiqing on glucose and lipid metabolism in genetically type 2 diabetes KK-Ay mice,” Journal of Health Science, vol. 54, no. 2, pp. 203–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-M. Kim, M.-H. Wang, and H.-I. Rhee, “A novel α-glucosidase inhibitor from pine bark,” Carbohydrate Research, vol. 339, no. 3, pp. 715–717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Tao, Z. Deqin, L. Yuhong et al., “Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine,” Journal of Ethnopharmacology, vol. 128, no. 3, pp. 575–582, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kageyama, N. Nakamichi, H. Sekino, and S. Nakano, “Comparison of the effects of acarbose and voglibose in healthy subjects,” Clinical Therapeutics, vol. 19, no. 4, pp. 720–729, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Huang, L. Kong, X. Li, X. Chen, M. Guo, and H. Zou, “Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines,” Journal of Chromatography B, vol. 812, no. 1-2, pp. 71–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Yanni and J. Jianqin, “Determination of Nuciferine in Lotus Leaf and petiole by HPLC,” Strait Pharmaceutical Journal, vol. 3, article 016, 2007. View at Google Scholar
  12. M. Zhou, H. Cai, Z. Huang, and Y. Sun, “HPLC method for the determination of paeoniflorin in Paeonia Lactiflare Pall and its preparations,” Biomedical Chromatography, vol. 12, no. 1, pp. 43–44, 1998. View at Google Scholar